| Dec 26, 2019 |
Dec 26, 2019 |
Groupon, Inc.
|
Director |
Sell |
17.5
|
-210,124
|
-19.83%
|
✓
|
$491K |
| Nov 12, 2019 |
Nov 12, 2019 |
Galera Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+416,666
|
10.57%
|
✗
|
$5M |
| Jul 22, 2019 |
Jul 24, 2019 |
Mirum Pharmaceuticals, Inc.
|
10% Owner |
Buy |
100.0
|
+450,000
|
12.04%
|
✗
|
$6.8M |
| May 9, 2019 |
May 13, 2019 |
Trevi Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+2,500,000
|
128.96%
|
✗
|
$25M |
| Mar 5, 2019 |
Mar 6, 2019 |
Mersana Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+3,750,000
|
46.07%
|
✗
|
$15M |
| Sep 7, 2018 |
Sep 10, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
100.0
|
+15,000,000
|
18.76%
|
✗
|
$25M |
| Jul 27, 2018 |
Jul 31, 2018 |
Bloom Energy Corp
|
10% Owner |
Buy |
100.0
|
+1,333,333
|
100.00%
|
✗
|
$20M |
| May 10, 2018 |
May 11, 2018 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Sell |
47.5
|
-9,539
|
-0.07%
|
✗
|
$169.9K |
| Mar 26, 2018 |
Mar 28, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
97.5
|
+6,571,164
|
8.95%
|
✗
|
$12.6M |
| Mar 21, 2018 |
Mar 23, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
87.5
|
+1,268,508
|
1.76%
|
✗
|
$2.4M |
| Feb 26, 2018 |
Feb 27, 2018 |
Oruka Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-1,460,209
|
-100.00%
|
✗
|
$731.3K |
| Dec 6, 2017 |
Dec 8, 2017 |
Senseonics Holdings, Inc.
|
10% Owner |
Sell |
37.5
|
-139,645
|
-0.45%
|
✗
|
$366.8K |
| Nov 27, 2017 |
Nov 27, 2017 |
APPIAN CORP
|
10% Owner |
Sell |
15.0
|
-569,620
|
-100.00%
|
✗
|
$11.1M |
| Nov 20, 2017 |
Nov 21, 2017 |
APPIAN CORP
|
10% Owner |
Sell |
15.0
|
-2,820,516
|
-100.00%
|
✗
|
$55M |
| Oct 10, 2017 |
Oct 10, 2017 |
RHYTHM PHARMACEUTICALS, INC.
|
10% Owner |
Buy |
100.0
|
+550,000
|
12.61%
|
✗
|
$9.4M |
| Aug 8, 2017 |
Aug 10, 2017 |
Groupon, Inc.
|
Director |
Sell |
17.5
|
-9,824,097
|
-91.03%
|
✗
|
$2.2M |
| Jul 3, 2017 |
Jul 6, 2017 |
Mersana Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+1,000,000
|
14.01%
|
✗
|
$15M |
| Jun 9, 2017 |
Jun 13, 2017 |
Groupon, Inc.
|
Director |
Sell |
20.0
|
-4,912,051
|
-31.38%
|
✗
|
$854.1K |
| Jun 1, 2017 |
Jun 5, 2017 |
Senseonics Holdings, Inc.
|
10% Owner |
Buy |
100.0
|
+7,092,198
|
26.93%
|
✗
|
$10M |
| Mar 27, 2017 |
Mar 28, 2017 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
100.0
|
+12,870,000
|
21.71%
|
✗
|
$9M |
| Mar 1, 2017 |
Mar 2, 2017 |
Groupon, Inc.
|
Director |
Sell |
20.0
|
-187,386
|
-1.18%
|
✗
|
$787.4K |
| Feb 27, 2017 |
Mar 1, 2017 |
Groupon, Inc.
|
Director |
Sell |
20.0
|
-4,724,666
|
-22.98%
|
✗
|
$399.9K |
| Aug 12, 2016 |
Aug 15, 2016 |
Groupon, Inc.
|
Director |
Sell |
17.5
|
-730,349
|
-3.43%
|
✗
|
$4.2M |
| Jul 18, 2016 |
Jul 20, 2016 |
ARDELYX, INC.
|
10% Owner |
Buy |
100.0
|
+2,290,951
|
19.43%
|
✗
|
$20M |
| Jun 8, 2016 |
Jun 10, 2016 |
Groupon, Inc.
|
Director |
Sell |
17.5
|
-10,781,944
|
-24.45%
|
✗
|
$2.1M |
| Mar 23, 2016 |
Mar 23, 2016 |
Senseonics Holdings, Inc.
|
10% Owner |
Buy |
100.0
|
+2,631,578
|
11.10%
|
✗
|
$7.5M |
| Jan 13, 2016 |
Jan 14, 2016 |
ARDELYX, INC.
|
10% Owner |
Buy |
100.0
|
+1,500,000
|
14.57%
|
✗
|
$15M |
| Nov 16, 2015 |
Nov 18, 2015 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Sell |
52.5
|
-452
|
-0.01%
|
✗
|
$3.1K |
| Oct 5, 2015 |
Oct 6, 2015 |
SYNLOGIC, INC.
|
10% Owner |
Buy |
100.0
|
+1,146,308
|
21.08%
|
✗
|
$6M |
| Jun 17, 2015 |
Jun 19, 2015 |
SUPERNUS PHARMACEUTICALS, INC.
|
10% Owner |
Buy |
45.0
|
-
|
0.00%
|
✗
|
$270K |
| Jun 15, 2015 |
Jun 17, 2015 |
SUPERNUS PHARMACEUTICALS, INC.
|
10% Owner |
Sell |
20.0
|
-2,813,314
|
-26.44%
|
✗
|
$928.7K |
| Jun 5, 2015 |
Jun 9, 2015 |
ARDELYX, INC.
|
10% Owner |
Buy |
100.0
|
+4,672,897
|
83.14%
|
✗
|
$50M |
| Dec 23, 2014 |
Dec 29, 2014 |
ARDELYX, INC.
|
10% Owner |
Sell |
51.3
|
-9,420
|
-0.17%
|
✗
|
$42K |
| Aug 27, 2014 |
Aug 29, 2014 |
Viracta Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-266,700
|
-5.41%
|
✗
|
$2.1M |
| Aug 8, 2014 |
Aug 12, 2014 |
Viracta Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-710,540
|
-12.61%
|
✗
|
$4.7M |
| Jan 15, 2014 |
Jan 15, 2014 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Buy |
100.0
|
+1,000,000
|
13.20%
|
✗
|
$8M |
| Dec 5, 2013 |
Dec 5, 2013 |
GYRE THERAPEUTICS, INC.
|
10% Owner |
Sell |
52.5
|
-1,000
|
-0.02%
|
✗
|
$5.1K |
| Nov 21, 2013 |
Nov 22, 2013 |
GYRE THERAPEUTICS, INC.
|
10% Owner |
Sell |
51.3
|
-5,333
|
-0.12%
|
✗
|
$27.5K |
| Jun 30, 2010 |
Jul 2, 2010 |
Viracta Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+23,824,451
|
100.00%
|
✗
|
$6.6M |